WCTC 2023 – LONDON, UK
WCTC has become established as the largest – and most highly regarded – International meeting dedicated to improving the care of patients with thyroid nodules and thyroid cancer. Clinically focused and taking a truly multi-disciplinary approach, this meeting is unique in attracting Surgeons, Endocrinologists, Medical Oncologists, Pathologists and other professionals dedicated to the field of thyroid oncology.
The previous in-person meetings had more than 1000 attendees, and the recent virtual programs have attracted more than 1500 unique, real-time attendees with thousands of additional viewers via the on-line content following the meetings.
WCTC is pleased to announce that our next in-person meeting will be in the fabulous city of London, UK June 15-17, 2023.
Under the direction of Dr. Neil Tolley and the WCTC Board, an exceptional educational program is being designed in addition to the opportunity to re-connect with our global colleagues.
We look forward to welcoming you to London next June.
HISTORY
- 2009 – Toronto, Canada
- 2013 – Toronto, Canada
- 2017 – Boston, USA
- 2019 – Rome, Italy
- 2021 / 2022 – virtual programming
- 2023 – London, UK
Make plans now to join your colleagues in London, UK in June. An exceptional scientific program will bring together leading global experts for a memorable experience.
The health and safety of WCTC attendees is our top priority. We will continuously monitor the ongoing global situation to ensure a safe environment at the Congress. Since we are in a constantly shifting environment, our health and safety protocols are subject to change. We reserve the right to institute additional safety measures as we near the Congress. Please check here for the current information.
For our international guests, we recommend checking your passport validity and visa requirements ASAP to be fully prepared for your attendance.
WCTC Mission Statement on Diversity, Equity and Inclusion (DEI)
The World Congress on Thyroid Cancer (WCTC) recognizes as self-evident that we can most effectively educate ourselves and our colleagues about the best care of patients with thyroid nodules and thyroid cancer when all relevant voices – including those of minority, disadvantaged and marginalized individuals – are heard and recognized. For this reason, we are committed to making the World Congress as welcoming as possible to members of all marginalized groups. We support cultural equity for all attendees and faculty, regardless of ethnicity, age, religion, disability, race, gender, sexual orientation, or any other individual or group identity. We will seek to prioritize attendance and program contributions from underrepresented groups in the World Congress. Furthermore, our Committee on Diversity, Equity and Inclusion will measure, analyze and report the effects of our actions regarding inclusive programming, cultural competence, and recognition of contributions from underrepresented groups. Through these means, we will strive to create a culture of access for all individuals, allowing those of all backgrounds and identities to feel welcomed and engaged in the World Congress.
Program
In support of improving patient care, this activity has been planned and implemented by the World Congress on Thyroid Cancer and CME Outfitters, LLC. CME Outfitters LLC. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Thyroid Cancer Learning Academy
The Thyroid Cancer Learning Academy is a content rich library of presentations by global experts from previous WCTC events. Delegates have free access for one year after their attendance. Additional access can be purchased at $125. The Academy is supported by an unrestricted educational grant from Eisai.
To navigate to the Thyroid Cancer Learning Academy, CLICK HERE.
